Predicting bacterial fitness cost associated with drug resistance

被引:40
|
作者
Guo, Beining [1 ,2 ]
Abdelraouf, Kamilia [1 ]
Ledesma, Kimberly R. [1 ]
Nikolaou, Michael [3 ]
Tam, Vincent H. [1 ,3 ]
机构
[1] Univ Houston, Coll Pharm, Dept Clin Sci & Adm, Houston, TX 77030 USA
[2] Fudan Univ, Inst Antibiot, Huashan Hosp, Shanghai 200433, Peoples R China
[3] Univ Houston, Dept Chem & Biomol Engn, Houston, TX USA
基金
美国国家科学基金会;
关键词
in vitro time growth; modelling; biofitness; multidrug-resistant bacteria; STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-RESISTANCE; PSEUDOMONAS-AERUGINOSA; VANCOMYCIN RESISTANCE; CONFERRING MUTATIONS; MULTIDRUG-RESISTANCE; BIOLOGICAL COST;
D O I
10.1093/jac/dkr560
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
It has been proposed that antimicrobial resistance could be associated with a fitness cost in bacteria, which is often determined by competition experiments between isogenic strains (wild-type and mutant). However, this conventional approach is time consuming and labour intensive. An alternative method was developed to assess the fitness cost in drug-resistant bacteria. Time-growth studies were performed with approximately 110(5) cfu/mL of Acinetobacter baumannii or Pseudomonas aeruginosa at baseline. Serial samples were obtained to quantify the bacterial burden over 24 h. The growth rates (K-g) of isogenic strains (antibiotic susceptible and resistant) were determined individually and used to predict their relative abundance in a co-culture over an extended period of time. The predicted difference between the two strains was subsequently validated by in vitro growth competition experiments. The growth rates of A. baumannii were not significantly different in different strengths of growth medium. The difference in bacterial burden observed in competition studies was in general agreement with the predicted difference based on K-g values, suggesting good predicting ability of the mathematical model. The proposed mathematical model was found to be reasonable in characterizing bacterial growth and predicting the fitness cost of resistance. This simple method appears robust in the assessment of fitness cost associated with drug resistance and warrants further investigations.
引用
收藏
页码:928 / 932
页数:5
相关论文
共 50 条
  • [1] Fitness cost of drug resistance in Mycobacterium tuberculosis
    Gagneux, S.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 : 66 - 68
  • [2] The epidemiological fitness cost of drug resistance in Mycobacterium tuberculosis
    Luciani, Fabio
    Sisson, Scott A.
    Jiang, Honglin
    Francis, Andrew R.
    Tanaka, Mark M.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (34) : 14711 - 14715
  • [3] Impact of Drug Resistance on Virulence and Fitness of Bacterial Pathogens Reply
    Kollef, Marin H.
    Burnham, Jason P.
    [J]. CRITICAL CARE MEDICINE, 2016, 44 (01) : E50 - E51
  • [4] Azole resistance in Aspergillus flavus and associated fitness cost
    Djenontin, Elie
    Debourgogne, Anne
    Mousavi, Bita
    Delhaes, Laurence
    Cornet, Muriel
    Valsecchi, Isabel
    Adebo, Makiath
    Guillot, Jacques
    Botterel, Francoise
    Dannaoui, Eric
    [J]. MYCOSES, 2024, 67 (07)
  • [5] Fitness cost of chromosomal drug resistance-conferring mutations
    Sander, P
    Springer, B
    Prammananan, T
    Sturmfels, A
    Kappler, M
    Pletschette, M
    Böttger, EC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) : 1204 - 1211
  • [6] Fitness cost and virulence associated with colistin resistance in Klebsiella pneumoniae
    Sedlaczek, L.
    Christ, S.
    Wichelhaus, T. A.
    Kempf, V. A. J.
    Ewers, C.
    Goettig, S.
    [J]. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2013, 303 : 88 - 89
  • [7] The fitness cost of mutations associated with human immunodeficiency virus type 1 drug resistance is modulated by mutational interactions
    Cong, Mian-er
    Heneine, Walid
    Garcia-Lerma, J. Gerardo
    [J]. JOURNAL OF VIROLOGY, 2007, 81 (06) : 3037 - 3041
  • [8] Fitness cost of antifungal resistance
    不详
    [J]. NATURE REVIEWS MICROBIOLOGY, 2022, 20 (11) : 637 - 637
  • [9] Fitness cost of antifungal resistance
    Grant Otto
    [J]. Nature Reviews Microbiology, 2022, 20 : 637 - 637
  • [10] Resistance of Aspergillus flavus clinical isolates and associated fitness-cost
    Djenontin, Elie
    Debourgogne, Anne
    Bergui, Imane
    Costa, Jean-Marc
    Mousavi, Bita
    Ait-Ammar, Nawel
    Guillot, Jacques
    Botterel, Francoise
    Dannaoui, Eric
    [J]. MEDICAL MYCOLOGY, 2022, 60 (SUPP 1) : 38 - 38